Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivoCANCER LETTERSIF10.12005-09-0112PRE
Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: Implication for anti-invasive role of HAI-21PB in glioblastoma cellsINTERNATIONAL JOURNAL OF CANCERIF4.72001-08-0156OA
Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironmentJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92000-12-01130OAAI
Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosaAMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGYIF3.32000-04-0160OAAI
Reduced expression of hepatocyte growth factor (HGF) activator inhibitor type-1 and enhanced activation of HGF in the early stage gastrointestinal carcinomas.GASTROENTEROLOGYIF25.12000-04-010PREAI
Expression of hepatocyte growth factor activator (HGFA) and its inhibitors (HAI) in damaged gastrointestinal tissue; Up regulation of HAI-1 along with the mucosal regeneration.GASTROENTEROLOGYIF25.12000-04-010PREAI
Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomasCANCER LETTERSIF10.12000-02-0130PRE
Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivoGASTROENTEROLOGYIF25.12000-01-0153PREAI
Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor scatter factor (HGF/SF) in human glioma cells: HGF SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMPINTERNATIONAL JOURNAL OF CANCERIF4.71999-07-1968OAAI
Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cellsCLINICAL & EXPERIMENTAL METASTASISIF3.21999-01-0131PREAI
Tl-201 uptake in an intracranial primary malignant melanomaCLINICAL NUCLEAR MEDICINEIF9.61996-07-016PRE